[Management and therapy of atrial fibrillation in geriatric patients]
- PMID: 22278008
- DOI: 10.1007/s00391-011-0268-0
[Management and therapy of atrial fibrillation in geriatric patients]
Abstract
Among geriatric patients, atrial fibrillation is the most common cardiac arrhythmia. In patients over 80 years of age, the prevalence rises to approximately 10%. Atrial fibrillation is associated with serious health implications, including a 2-fold increase in mortality risk and a 5-fold increase in stroke risk. In contrast to these facts, the current guidelines on the management of atrial fibrillation of the European Society of Cardiology (ESC) contain only a short paragraph on these patients. Many relevant clinical aspects go without any comment. Thus, the purpose of our paper is to discuss those special needs of geriatric patients and their physicians which are not mentioned in the guidelines of the ESC. In our review, we discuss rhythm versus rate control, oral anticoagulation, outcome, prevention, falls, adherence, polypharmacy, dementia, nursing home patients, frailty, and geriatric assessment in consideration of geriatric patients. An extended search of the literature on Pubmed served as the basis for this review. Individual aspects of each geriatric patient should be considered when managing these complex patients; however, the complexity of each case must not lead to an individualized therapy that is not in accordance with current guidelines and the literature. A large number of papers which help us to answer most of the clinical questions regarding the management of trial fibrillation in geriatric patients have already been published.
Similar articles
-
[Update atrial fibrillation in older adults].Z Gerontol Geriatr. 2024 Dec;57(8):659-667. doi: 10.1007/s00391-024-02375-4. Epub 2024 Nov 8. Z Gerontol Geriatr. 2024. PMID: 39514024 Review. German.
-
Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people.Arch Cardiovasc Dis. 2013 May;106(5):303-23. doi: 10.1016/j.acvd.2013.04.001. Epub 2013 May 29. Arch Cardiovasc Dis. 2013. PMID: 23769405
-
Atrial fibrillation: state of the art.Wien Klin Wochenschr. 2014 Nov;126(21-22):692-704. doi: 10.1007/s00508-014-0667-5. Epub 2014 Nov 20. Wien Klin Wochenschr. 2014. PMID: 25409952 Review.
-
Overview of the management of atrial fibrillation: what is the current state of the art?J Cardiovasc Electrophysiol. 2003 Dec;14(12 Suppl):S275-80; discussion S280. doi: 10.1046/j.1540-8167.2003.90405.x. J Cardiovasc Electrophysiol. 2003. PMID: 15005214 Review.
-
Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines.Eur Geriatr Med. 2022 Feb;13(1):5-18. doi: 10.1007/s41999-021-00537-w. Epub 2021 Nov 2. Eur Geriatr Med. 2022. PMID: 34727362 Free PMC article. Review.
Cited by
-
[Falls and dementia are not contraindications for anticoagulation in older adults with atrial fibrillation].Z Gerontol Geriatr. 2016 Jul;49(5):458-9. doi: 10.1007/s00391-016-1088-z. Z Gerontol Geriatr. 2016. PMID: 27334314 German. No abstract available.
-
[Tools for optimizing pharmacotherapy for geriatric patients with multimorbidity at the end of life: helpful oder just raising awareness?].Wien Med Wochenschr. 2014 May;164(9-10):189-94. doi: 10.1007/s10354-014-0274-0. Epub 2014 Apr 9. Wien Med Wochenschr. 2014. PMID: 24715194 German.
-
[Digitalis and theophylline: old and superfluous?].Z Gerontol Geriatr. 2013 Jul;46(5):479-86; quiz 486-7. doi: 10.1007/s00391-013-0497-5. Z Gerontol Geriatr. 2013. PMID: 23780629 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical